Innovation and Commercialisation in the Biopharmaceutical Industry

Download or read book Innovation and Commercialisation in the Biopharmaceutical Industry written by Bruce Rasmussen and published by Edward Elgar Pub. This book was released on 2010-01-01 with total page 326 pages. Available in PDF, EPUB and Kindle. Book excerpt: `The processes of discovery, testing and distribution of new medicines have undergone radical change in recent decades, from a focus on small molecule drugs to biomedicine and related technologies. Bruce Rasmussen very effectively draws upon modern theories of the firm, data analysis, and case studies to provide important insights into the consequences of this change. He offers convincing evidence that contradicts the widely-held view that the biopharmaceutical sector has not generated considerable economic value.'---Frank R. Lichtenberg, Columbia University, USA `Bio- and pharmaceutical industry discovery is a distressed asset today. Why? Bruce Rasmussen's book is a timely and very informative work, building on rich data sources and extensive economic research, on a subject of concern to us all. Is medicine discovery in permanent decline? Are the biotechnology and traditional pharma groups on a collision course, will the traditional group absorb the new, will integration take place, will a new discovery model emerge? I commend Bruce's book to all who wish to understand what is happening.'---David W. Anstice, Merck & Co., Inc. This path-breaking book addresses the ongoing implications for traditional pharmaceutical companies and biopharmaceutical start-ups of the realignment of the industry knowledge-base. The theoretical approach draws on the modern theory of the firm and related ideas in order to better define the concept of the business model, which is employed to guide the case studies and empirical analysis in the book.